Zai Lab

Zai Lab Equity Growth

The Year-over-Year Equity Growth of Zai Lab (ZLAB) as of Nov 22, 2026 is -14.91 %. In the previous year, Year-over-Year Equity Growth was 5.62 % — a change of -365.12% (lower).

Equity Growth

-14.91 %

YoY

-365.12%

Last updated:

Year-over-Year Equity Growth of Zai Lab is 2025 -14.91 % . Year-over-Year Equity Growth of Zai Lab was 2024 5.62 % . It decreases by -365.12% lower compared to the previous year.

The Zai Lab Equity Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity Growth
Date
Equity Growth
Jan 1, 2018
6.77 USD
Jan 1, 2019
17.36 USD
Jan 1, 2020
296.85 USD
Jan 1, 2021
18.01 USD
Jan 1, 2022
-24.23 USD
Jan 1, 2023
-23.86 USD
Jan 1, 2024
5.62 USD
Jan 1, 2025
-14.91 USD
The Zai Lab Equity Growth history
YEAREquity GrowthYoY
-14.91 %-365.12%
5.62 %-123.57%
-23.86 %-1.53%
-24.23 %-234.53%
18.01 %-93.93%
296.85 %+1,610.31%
17.36 %+156.54%
6.77 %-98.78%
556.18 %-407.91%
-180.63 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Zai Lab Stock analysis

What does Zai Lab do? Zai Lab Ltd, based in Pudong, China, is a biopharmaceutical company operating in the Health Care sector. It develops and commercializes innovative treatments for oncology, immunology, neuroscience, and infectious diseases. The company offers products such as Zejula for ovarian cancer, VYVGART for myasthenia gravis, NUZYRA for bacterial infections, Optune for brain tumors, Qinlock for gastrointestinal tumors, Xacduro for bacterial pneumonia, and Augtyro for lung cancer. Zai Lab collaborates with leading pharmaceutical firms including Pfizer and Amgen. Zai Lab is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Zai Lab stock

Year-over-Year Equity Growth of Zai Lab is -14.91 % in 2025.

On Eulerpool you can find the complete historical development of Year-over-Year Equity Growth Zai Lab since 2006 – with annual values, charts, and detailed analysis.

Equity growth measures the percentage change in shareholders' equity. It reflects retained earnings, share issuances, and comprehensive income effects.

To evaluate Year-over-Year Equity Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Equity Growth.

Year-over-Year Equity Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Equity Growth's Zai Lab historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Zai Lab

All Key Metrics — Zai Lab